TP53 and cancer: Early studies of the oncogenic role of BCL3 naturally focused on NF-kB mediated pathways in cancer, most notably the transcriptional control of cyclin D1 and p53 to regulate cell cycle [98–103], and cell viability (including p53 mediated apoptosis) [58, 104–106].